GLYCOPYRROLATE

Standard Prescription

glycopyrrolate__mcg IV{PO} Q   H (__mcg/kg/dose)

Dosages

Control of secretions/respiratory antisecretory:
Children:
PO: 40-100 mcg/kg/dose TID to QID Max.: 2 mg/dose)
IV/SC: 4-10 mcg/kg/dose IV Q4-8H. Max 0.2 mg/dose, 0.8 mg/24h

Adult:
PO/SL/SC: 200-400 mcg/dose Q4-8H. Max: 4 doses/24h

Mechanism of Action

Anticholinergic 

Forms Supplied

Injection: 0.2 mg/mL; 1 mL amps
Oral suspension (BCCH): 0.5 mg/mL

Comments

Nausea, constipation, urinary retention, dry mouth, blurred vision, cardiac dysrhythmia.

Use with caution in hepatic and renal disease, ulcerative colitis, asthma, glaucoma, ileus or urinary retention

Injection form may be used orally

References

44, 248, 640, 641, 642

Last Edited

2022-07-03 02:35:24